In the original article, there was a mistake in the order of figures for Figures 1–3 as published. Figure 1 should be Figure 3, Figure 2 should be Figure 1, and Figure 3 should be Figure 2. The legends and references in the manuscript for all three figures were correct. The corrected Figures 1–3 appear below.
Figure 1
Figure 2
Figure 3
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
hepatitis B, nucleos(t)ide therapy, therapy costs, treatment guidelines, treatment gap, hepatitis elimination
Citation
Maisa A, Kollan C, an der Heiden M, van Bömmel F, Cornberg M, Mauss S, Wedemeyer H, Schmidt D and Dudareva S (2022) Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019. Front. Public Health 10:860836. doi: 10.3389/fpubh.2022.860836
Received
23 January 2022
Accepted
11 February 2022
Published
11 March 2022
Volume
10 - 2022
Edited and reviewed by
Zhiliang Hu, Nanjing Second Hospital, China
Updates
Copyright
© 2022 Maisa, Kollan, an der Heiden, van Bömmel, Cornberg, Mauss, Wedemeyer, Schmidt and Dudareva.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sandra Dudareva dudarevas@rki.de
This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Public Health
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.